Evidence map›Paper›PMID 18455505›Full record

ArticleBiochemical and biophysical research communications2008

Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein.

Ewa Krawczyk, John A Hanover, Richard Schlegel, Frank A Suprynowicz

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Karyopherins in cancer.Current opinion in cell biology · 2018
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. The E5 proteins.Virology · 2013
    Review
  12. Article
  13. Intrinsic and extrinsic negative regulators of nuclear protein transport processes.Genes to cells : devoted to molecular & cellular mechanisms · 2012
    Review
  14. Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.Cellular oncology (Dordrecht, Netherlands) · 2012
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ewa KrawczykDepartment of Pathology, Georgetown University Medical School, 3900 Reservoir Road NW, Washington, DC 20057, USA.
John A Hanover
Richard Schlegel
Frank A Suprynowicz
Georgetown University Medical Center · USNational Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

Calmodulin-driven Nuclear Trafficking linked to diabetes and insulin signalingZIADK060102 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HANOVER, JOHN A. · 2009 to 2025
$8.5M
PAPILLOMAVIRUS E5 ONCOPROTEIN AND CELL TRANSFORMATIONR01CA053371 · NCI · GEORGETOWN UNIVERSITY · PI SCHLEGEL, RICHARD · 1991 to 2010
$5.0M
Enzymes of O-GlcNAc cycling linked to type-2 diabetes and neurodegenerationZ01DK060103 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HANOVER, JOHN A. · 2007 to 2008
$744k
NCI NIH HHS R01 CA053371NCI NIH HHS R01-CA053371
6 · The paper itself

Abstract

Epidemiological and experimental studies have shown that high-risk human papillomaviruses (HPVs) are the causative agents of cervical cancer worldwide, and that HPV-16 is associated with more than half of these cases. In addition to the well-characterized E6 and E7 oncoproteins of HPV-16, recent evidence increasingly has implicated the HPV-16 E5 protein (16E5) as an important mediator of oncogenic transformation. Since 16E5 has no known intrinsic enzymatic activity, its effects on infected cells are most likely mediated by interactions with various cellular proteins and/or its documented association with lipid rafts. In the present study, we describe a new cellular target that binds to 16E5 in COS cells and in stable human ectocervical cell lines. This target is karyopherin beta3, a member of the nuclear import receptor family with critical roles in the nuclear import of ribosomal proteins and in the secretory pathway.

Indexed as

Amino Acid SequenceAnimalsbeta KaryopherinsChlorocebus aethiopsCOS CellsHumansMolecular Sequence DataOncogene Proteins, ViralViroporin Proteinsbeta KaryopherinsIPO5 protein, humanoncogene protein E5, Human papillomavirus type 16Oncogene Proteins, ViralViroporin Proteins

Identifiers

PMID18455505
PMCPMC2773212
OpenAlexW2082811207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.